Abstract 4455: Discovery of AMG 510, a first-in-human covalent inhibitor of KRASG12C for the treatment of solid tumors

克拉斯 神经母细胞瘤RAS病毒癌基因同源物 赫拉 癌症研究 西妥昔单抗 表皮生长因子受体抑制剂 激酶 胰腺癌 结直肠癌 生物 化学 癌症 表皮生长因子受体 生物化学 遗传学
作者
Brian A. Lanman,Jian Jeffrey Chen,Longbin Liu,Patricia Lopez,Alexander J. Pickrell,Anthony B. Reed,Huiling Wang,Pragathi Achanta,Jude R. Canon,Daniel A. Erlanson,Raymond V. Fucini,Joon Won Jeong,Christopher Mohr,Anne Y. Saiki,Victor J. Cee,James Russell Lipford,Karen L. Rex,Laurie P. Volak
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:79 (13_Supplement): 4455-4455 被引量:9
标识
DOI:10.1158/1538-7445.am2019-4455
摘要

Abstract The RAS gene family encodes the small GTPase proteins NRAS, HRAS, and KRAS, which play an essential role in cellular growth and proliferation. KRAS is one of the most frequently mutated oncogenes in human cancer, with KRAS p.G12D, p.G12V, and p.G12C constituting the major mutational subtypes across lung, colon, and pancreatic cancers. Despite more than three decades of research, indirect approaches targeting KRAS mutant cancers have largely failed to show clinical benefit, and direct approaches have been stymied by the apparently ‘undruggable’ nature of KRAS. Cysteine-12 of KRASG12C has recently emerged as a unique vulnerability in KRAS-mutant cancers, and a small number of cysteine-reactive inhibitory tool molecules have been disclosed. We here report independent efforts to identify cysteine-reactive molecules capable of selectively inhibiting KRASG12C. Through iterative screening and structural biology efforts, we identified a novel Cys12-reactive inhibitor scaffold that derived its potency from occupancy of a previously unknown cryptic pocket induced by side-chain motion of the His95 residue of KRAS. Employing a scaffold-hopping approach, we leveraged knowledge of this cryptic pocket to design a series of N-aryl quinazolin-2(1H)-one-based inhibitors that demonstrated significantly enhanced potency relative to prior tool compounds. Extensive optimization of these leads led to the identification of a highly potent, selective, and well-tolerated inhibitor of KRASG12C, which was nominated for clinical development as AMG 510. In preclinical tumor models, AMG 510 rapidly and irreversibly binds to KRASG12C, providing durable suppression of the mitogen-activated protein kinase (MAPK) signaling pathway. Dosed orally (once daily) as a single agent, AMG 510 is capable of inducing tumor regression in mouse models of KRASG12C cancer. AMG 510 is, to the best of our knowledge, the first direct KRASG12C therapeutic to reach human clinical testing and is currently in a Phase I clinical trial evaluating safety, tolerability, PK, and efficacy in subjects with solid tumors bearing the KRAS p.G12C mutation (NCT03600883). Citation Format: Brian A. Lanman, Jian Jeffrey Chen, Longbin Liu, Patricia Lopez, Alexander J. Pickrell, Anthony B. Reed, Hui-Ling Wang, Pragathi Achanta, Jude Canon, Daniel A. Erlanson, Raymond V. Fucini, Joon Won Jeong, Christopher Mohr, Anne Y. Saiki, Victor J. Cee, J. Russell Lipford, Karen Rex, Laurie P. Volak. Discovery of AMG 510, a first-in-human covalent inhibitor of KRASG12C for the treatment of solid tumors [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4455.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
donkey发布了新的文献求助10
刚刚
1秒前
初景发布了新的文献求助10
1秒前
1秒前
汉堡包的应助被务实一斩采纳,获得10
1秒前
昏睡的帆布鞋完成签到 ,获得积分10
1秒前
学术laji发布了新的文献求助10
1秒前
2秒前
Yeiur发布了新的文献求助10
2秒前
2秒前
2秒前
2秒前
2秒前
昕昕233发布了新的文献求助10
2秒前
龙达绝澈完成签到,获得积分10
3秒前
个性向卉发布了新的文献求助10
4秒前
笨笨小天鹅完成签到,获得积分10
5秒前
冷艳的寒天的应助被YananLi采纳,获得10
5秒前
zzh_zxc完成签到,获得积分10
5秒前
斯文败类的应助被yaya采纳,获得10
5秒前
5秒前
guo完成签到 ,获得积分10
6秒前
6秒前
fantasy的应助被yuyu采纳,获得10
6秒前
Smile_Uo完成签到,获得积分10
7秒前
龙达绝澈发布了新的文献求助10
7秒前
奋斗小真发布了新的文献求助10
7秒前
三星导弹船完成签到,获得积分10
7秒前
8秒前
北斋完成签到,获得积分10
8秒前
LEESO完成签到,获得积分10
8秒前
Maestro_S的应助被wary采纳,获得10
9秒前
9秒前
123发布了新的文献求助10
10秒前
SunnyLife完成签到,获得积分10
11秒前
11秒前
十三完成签到 ,获得积分10
11秒前
吕大本事发布了新的文献求助10
11秒前
玛卡巴卡完成签到,获得积分10
11秒前
彭于晏的应助被兴奋石头采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187612
求助须知:如何正确求助?哪些是违规求助? 9575734
关于积分的说明 21842594
捐赠科研通 7785476
什么是DOI,文献DOI怎么找? 3435073
关于科研通互助平台的介绍 2559478
邀请新用户注册赠送积分活动 2481952